Related Experiment Video

Updated: Apr 30, 2026

Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

13.6K

[The prognostic value of biochemical indicators under neonatal hepatitis of different etiology]

L A Alekseeva, T V Bessonova, L G Goriacheva

    Klinicheskaia Laboratornaia Diagnostika
    |April 25, 2014
    PubMed

    Insights

    Neonatal hepatitis in children is increasingly linked to genetic factors, biliary malformations, and infections. Detecting acute-phase proteins aids in assessing inflammation, improving prognosis, and guiding therapy for better outcomes.

    Area of Science:

    • Pediatric Hepatology
    • Biochemistry
    • Neonatal Medicine

    Context:

    • Rising incidence of neonatal hepatitis attributed to genetic predisposition, biliary tract malformations, and congenital hepatobiliary infections.
    • Neonatal hepatitis presents a significant challenge in early childhood, impacting liver function and development.

    Purpose:

    • To investigate biochemical changes in neonatal hepatitis, focusing on acute-phase proteins.
    • To correlate biochemical profiles with etiological factors and disease progression in infants and young children.

    Summary:

    • A biochemical study of 62 children (1.5 months–2 years) with neonatal hepatitis revealed moderate changes in cytolysis, cholestasis, and protein metabolism indicators.
    • Elevated acute-phase protein concentrations correlated with inflammation. Peak biochemical changes were observed in children with hepatobiliary malformations linked to herpes viruses and those developing liver fibrosis within the first year.
    • Acute-phase proteins, including C-reactive protein, alpha2-macroglobulin, and alpha1-antitripsin, are valuable for evaluating prolonged liver inflammation and prognosis.

    Impact:

    • Detection of acute-phase proteins offers objective assessment of liver inflammation, aiding in prognosis and timely therapeutic correction for improved outcomes in neonatal hepatitis.
    • Recommends incorporating C-reactive protein, alpha2-macroglobulin, and alpha1-antitripsin into the diagnostic algorithm for neonatal hepatitis.

    More Related Videos

    Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen09:44

    Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

    Published on: November 27, 2019

    10.7K
    Isolation of Neonatal Extrahepatic Cholangiocytes07:54

    Isolation of Neonatal Extrahepatic Cholangiocytes

    Published on: June 5, 2014

    10.1K

    Related Concept Videos

    Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

    Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

    In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
    271
    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
    410
    Jaundice01:25

    Jaundice

    Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
    35